HUTCHMED (China) (HCM) Asset Utilization Ratio (2019 - 2021)

HUTCHMED (China) (HCM) posted quarterly Asset Utilization Ratio of 0.46 for Q4 2021, up 65.62% quarter-over-quarter from 0.28 in Q1 2021.

HUTCHMED (China) (HCM) Asset Utilization Ratio (2019 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has reported Asset Utilization Ratio for 3 consecutive years, with 0.46 the latest figure, recorded in Q4 2021.

In Q4 2021, Asset Utilization Ratio changed N/A year-over-year to 0.46; the TTM figure through Dec 2021 stood at 0.46 (changed N/A YoY), while the FY2025 annual figure was 0.0, up 3689.66% from the prior year.
Asset Utilization Ratio advanced to 0.46 in Q4 2021 per HCM's latest filing, from 0.28 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 0.5 in Q1 2020 and bottomed at 0.28 in Q1 2021.
Historically, Asset Utilization Ratio has averaged 0.43 across 3 years, with a median of 0.44 in 2019.
Annual changes were most pronounced in 2020 — Asset Utilization Ratio increased 24.13% — and 2021, when it sank 43.7%.
HUTCHMED (China)'s Asset Utilization Ratio stood at 0.47 in 2019, then dropped by 5.56% to 0.45 in 2020, then climbed by 3.47% to 0.46 in 2021.
Business Quant data shows HCM's Asset Utilization Ratio at 0.46 in Q4 2021, 0.28 in Q1 2021, and 0.45 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Haleon	43.85 Bn	42.88 Bn	-	-
2	Teva Pharmaceutical Industries	43.02 Bn	39.37 Bn	2.15 Bn	0.43
3	Zoetis	31.47 Bn	29.79 Bn	1.05 Bn	0.63
4	Takeda Pharmaceutical	28.59 Bn	22.79 Bn	5.10 Bn	0.47
5	United Therapeutics	22.20 Bn	19.53 Bn	683.80 Mn	0.45
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn	0.41
7	Neurocrine Biosciences	15.45 Bn	15.06 Bn	935.80 Mn	0.66
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	0.37
9	Dr Reddys Laboratories	10.10 Bn	9.94 Bn	-	-
10	HUTCHMED (China)	2.18 Bn	2.18 Bn	-	-

Download Data